Thank you for your thoughts Andrew and Timbo. While I have zero...

First 20 Last

Share
Profile

Follow
rogues

1,695 Posts.

1174

30/09/17

18:57

Post #: 27573090
Share

Originally posted by andrewk65 ↑

I know. I think i'm a bit slow but it finally sank in. The MYC could be a master stroke as there is much interest in that area. Granted we may not be able to make money off it quickly but I do think that Dr Soucek's research was regarded highly by her peers and industry in general, and their stumbling block had always been actually being able to enter cells with their omomyc. We managed to achieve this so not only did we show those currently focused on PYC that we could achieve this goal, but also hopefully we showed anyone who was following Dr Soucek's research that we had achieved a major step that unfortunately the creators of Omomyc had apparently struggled with. Those interested in Omomyc may well have other interests that could be helped by a "tractor" that has been shown to drag various payloads into cells and escape endsome. One would think that as long as it is safe and non toxic, which appears to be the case then surely this is the start of a very large new class of drugs. Again we just need to stop calling ourselves an Oncology company I think. We'd almost be better branding ourself as a (legal) drug courier lol.

Expand

Thank you for your thoughts Andrew and Timbo.
While I have zero in technology understanding/qualification, I am very heartened to have gained the impression our leaders are very focussed on commercialising the very developments you relate to.
Big Pharma may well be accelerating their interest, we could all be onto a screamer here, -I'm ready when you are... GLTA

PYC Price at posting: 4.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Expert Exchange: It's half time Down Under – How are we faring?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: Grand Nvidia comeback turns into 'sell' signpost for traders | June 26

PTX

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

First 20 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.29		Change 0.000(0.00%)		Mkt cap ! $749.4M

Open	High	Low	Value	Volume
$1.29	$1.29	$1.29	$7.752K	6.033K

Buyers (Bids)

No.	Vol.	Price($)
3	22644	$1.24

Sellers (Offers)

Price($)	Vol.	No.
$1.28	1106	1

View Market Depth

No.	Vol.	Price($)
3	22644	1.240
1	300	1.230
1	4000	1.225
1	20000	1.220
1	4000	1.200

Price($)	Vol.	No.
1.285	58937	2
1.295	24500	1
1.300	8000	1
1.325	9001	1
1.330	10756	2

Last trade - 10.34am 26/06/2025 (20 minute delay)

PYC (ASX) Chart

Thank you for your thoughts Andrew and Timbo. While I have zero...

Expert Exchange: It's half time Down Under – How are we faring?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: Grand Nvidia comeback turns into 'sell' signpost for traders | June 26

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thank you for your thoughts Andrew and Timbo. While I have zero...

Top Stories

Expert Exchange: It's half time Down Under – How are we faring?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: Grand Nvidia comeback turns into 'sell' signpost for traders | June 26

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News